Literature DB >> 11866740

Fungemia: An increasing problem in a Danish university hospital 1989 to 1994.

Brita Bruun1, Henrik Westh, Jørgen Stenderup.   

Abstract

OBJECTIVE: To present data on episodes of fungemia in a Danish tertiary-care university hospital admitting all types of patients and to compare the data with previous findings from the same hospital.
METHODS: Retrospective identification of episodes of fungemia from 1989 to 1994 and collection of data from computerized files at the Clinical Microbiology Department at Rigshospitalet and the Mycology Reference Laboratory at Statens Seruminstitut.
RESULTS: The incidence of fungemia increased gradually from 19 episodes in 1989 to 57 episodes in 1994. An earlier report from the same hospital showed 20 to 25 episodes of fungemia per year between 1984 and 1988. Candida albicans was the dominating species during both periods, accounting for 73% of isolates during 1984 to 1988 and 67% during 1989 to 1994. However, in the hematology department where fluconazole has been used extensively, C. albicans constituted 47% of isolates with Candida krusei and Candida glabrata comprising 25%.
CONCLUSIONS: The incidence of fungemia in our tertiary-care hospital has increased threefold from 1989 to 1994. Candida albicans was the dominating cause of fungemia but, in the hematology department, this yeast accounted for less than half of the isolates during the same time period.

Entities:  

Year:  1995        PMID: 11866740     DOI: 10.1111/j.1469-0691.1995.tb00456.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.

Authors:  Maiken Cavling Arendrup; Kurt Fuursted; Bente Gahrn-Hansen; Irene Møller Jensen; Jenny Dahl Knudsen; Bettina Lundgren; Henrik C Schønheyder; Michael Tvede
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals.

Authors:  A Voss; J A Kluytmans; J G Koeleman; L Spanjaard; C M Vandenbroucke-Grauls; H A Verbrugh; M C Vos; A Y Weersink; J A Hoogkamp-Korstanje; J F Meis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

3.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms.

Authors:  B Graf; T Adam; E Zill; U B Göbel
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 5.  Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.

Authors:  M Kalin; B Petrini
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

6.  Detection of fluconazole-resistant Candida strains by a disc diffusion screening test.

Authors:  P Sandven
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

8.  Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.

Authors:  P Sandven; L Bevanger; A Digranes; P Gaustad; H H Haukland; M Steinbakk
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.